The rising interest in GLP-1 agonists for diabetes has generated a debate about formats: skin-applied devices versus pills . Traditionally , GLP-1 treatments were solely available in oral form, but the https://neilpvon585008.iyublog.com/39763597/glp-1-patches-vs-oral-medications-which-best-for-the-patient